NCT01017484

Brief Summary

Understanding the possible mechanism(s) by which the DASH dietary pattern lowers blood pressure will potentially enhance the value of this dietary intervention by elucidating the conditions under which it will be most effective, identifying target populations, examining its impact on vascular health beyond blood pressure, and enhancing the investigators' understanding of the interactions among diet, blood pressure and vascular function. In addition, results of this study may help to identify additional therapeutic targets. Therefore, the overall goal of the proposed study is to determine the mechanism(s) by which the DASH dietary pattern lowers blood pressure by using a controlled feeding design.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2007

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 19, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 20, 2009

Completed
Last Updated

April 11, 2013

Status Verified

November 1, 2009

Enrollment Period

1.9 years

First QC Date

November 19, 2009

Last Update Submit

April 9, 2013

Conditions

Keywords

blood pressureDASH diethypertension

Outcome Measures

Primary Outcomes (1)

  • urinary sodium

    2 weeks

Secondary Outcomes (1)

  • blood pressure

    2 weeks

Study Arms (2)

DASH

EXPERIMENTAL

The Dietary Approaches to Stop Hypertension Dietary pattern.

Other: DASH, Control

Control

EXPERIMENTAL

The typical American diet as estimated from the NHANES survey.

Other: DASH, Control

Interventions

controlled feeding of either the DASH dietary pattern or a typical American diet at isocaloric level.

ControlDASH

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • SBP 140-159 mm Hg and DBP 90-99 mm Hg based on mean values over two screening visits,
  • Age ≥22 years, and
  • Willing to eat at least one on-site meal/day, five days/week, and willing to eat study diets and nothing else for the 3 weeks of controlled feeding.

You may not qualify if:

  • Any serious illness that would interfere with participation or make DASH diet unsafe to the participants,
  • Currently on cancer chemotherapy or with evidence of active malignancy or radiation therapy within past six months,
  • History of CVD event (MI, CABG, angioplasty, symptomatic ischemic heart disease, or stroke),
  • Clinical diagnosis of congestive heart failure,
  • Current diagnosis of diabetes and treatment for diabetes with oral medication or insulin,
  • Body mass index \> 45 Kg/m2,
  • DASH MECHANISM staff or household member of DASH MECHANISM staff,
  • Using Medications including BP lowering drugs within the last three months, using lithium,insulin or oral diabetes medications, oral corticosteroids, unstable doses of psychotropics or phenothiazines, antacids or nutritional supplements unless they can be discontinued, or weight reducing medications;
  • Consumption of more than 14 alcoholic drinks per week;
  • Investigator discretion for safety or compliance reasons;
  • Inability to provide reliable BP \& vascular functions measurements;
  • Planning to leave the area prior to the anticipated end of the intervention period;
  • Pregnant, planning a pregnancy prior to the end of intervention, or breast feeding;
  • Significant food allergies, preferences, or dietary requirements that would interfere with diet adherence; and
  • Subjects taking medications for erectile dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Pao-Hwa Lin, PhD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2009

First Posted

November 20, 2009

Study Start

July 1, 2007

Primary Completion

June 1, 2009

Study Completion

June 1, 2009

Last Updated

April 11, 2013

Record last verified: 2009-11